No profile data available.
Armata Pharmaceuticals, Inc. (ARMP) is a healthcare company in the antibacterial pharmaceuticals industry, based in Los Angeles, United States, with about 61 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$173.80 million. Its market capitalization was $134.97 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.
Armata Pharmaceuticals reported $0 in revenue for fiscal year 2025.
$134.97 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antibacterial pharmaceuticals) include Vaxcyte, Inc. (PCVX), AN2 Therapeutics, Inc. (ANTX), BGM Group Ltd. (BGM), PolyPid Ltd. (PYPD).